CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects

Stefanie L. Slezak, Maria Bettinotti, Silvia Selleri, Sharon Adams, Francesco M. Marincola, David F. Stroncek

Research output: Contribution to journalArticle

Abstract

Background: Adoptive immune and vaccine therapies have been used to prevent cytomegalovirus (CMV) disease in recipients of hematopoietic progenitor cell transplants, but the nature of T cell responses to CMV have not been completely characterized. Methods: Peptide pools and indi vidual peptides derived from the immune-dominant CMV proteins pp65 and IE-1 and antigen-specific, cytokine flow cytometry were used to characterize the prevalence and frequency of CD4+ and CD8+ memory T cells in 20 healthy CMV-seropositive subjects. Results: CD8+ T cell responses to pp65 were detected in 35% o f subjects and to IE-1 in 40% of subjects. CD4+ T cell responses to pp65 were detected in 50% of subjects, but none were detected to IE-1. Several new IE-1 HLA class I epitopes were identified, including 4 restricted to HLA-C antigens. One region of IE-1 spanning amino acids 300 to 327 was rich in class I epitopes. The HLA class I restrictions of IE-1 peptides were more promiscuous than those of pp65 peptides. Conclusion: Since na turally occurring CD4+ and CD8+ T cell responses to pp65 were detectable in many subjects, but only CD8+ T cell responses to IE-1 were detected, pp65 may be better than IE-1 for use in vaccine and adoptive immune therapies.

Original languageEnglish (US)
Article number17
JournalJournal of Translational Medicine
Volume5
DOIs
StatePublished - 2007
Externally publishedYes

Fingerprint

T-Lymphocyte Epitopes
T-cells
Cytomegalovirus
Healthy Volunteers
T-Lymphocytes
Peptides
Epitopes
Vaccines
HLA-C Antigens
Active Immunotherapy
Transplants
Flow cytometry
Hematopoietic Stem Cells
Flow Cytometry
Cytokines
Antigens
Data storage equipment
Amino Acids

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects. / Slezak, Stefanie L.; Bettinotti, Maria; Selleri, Silvia; Adams, Sharon; Marincola, Francesco M.; Stroncek, David F.

In: Journal of Translational Medicine, Vol. 5, 17, 2007.

Research output: Contribution to journalArticle

Slezak, Stefanie L. ; Bettinotti, Maria ; Selleri, Silvia ; Adams, Sharon ; Marincola, Francesco M. ; Stroncek, David F. / CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects. In: Journal of Translational Medicine. 2007 ; Vol. 5.
@article{1457b99dcf0946d6a8741806f56c5ccd,
title = "CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects",
abstract = "Background: Adoptive immune and vaccine therapies have been used to prevent cytomegalovirus (CMV) disease in recipients of hematopoietic progenitor cell transplants, but the nature of T cell responses to CMV have not been completely characterized. Methods: Peptide pools and indi vidual peptides derived from the immune-dominant CMV proteins pp65 and IE-1 and antigen-specific, cytokine flow cytometry were used to characterize the prevalence and frequency of CD4+ and CD8+ memory T cells in 20 healthy CMV-seropositive subjects. Results: CD8+ T cell responses to pp65 were detected in 35{\%} o f subjects and to IE-1 in 40{\%} of subjects. CD4+ T cell responses to pp65 were detected in 50{\%} of subjects, but none were detected to IE-1. Several new IE-1 HLA class I epitopes were identified, including 4 restricted to HLA-C antigens. One region of IE-1 spanning amino acids 300 to 327 was rich in class I epitopes. The HLA class I restrictions of IE-1 peptides were more promiscuous than those of pp65 peptides. Conclusion: Since na turally occurring CD4+ and CD8+ T cell responses to pp65 were detectable in many subjects, but only CD8+ T cell responses to IE-1 were detected, pp65 may be better than IE-1 for use in vaccine and adoptive immune therapies.",
author = "Slezak, {Stefanie L.} and Maria Bettinotti and Silvia Selleri and Sharon Adams and Marincola, {Francesco M.} and Stroncek, {David F.}",
year = "2007",
doi = "10.1186/1479-5876-5-17",
language = "English (US)",
volume = "5",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",

}

TY - JOUR

T1 - CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects

AU - Slezak, Stefanie L.

AU - Bettinotti, Maria

AU - Selleri, Silvia

AU - Adams, Sharon

AU - Marincola, Francesco M.

AU - Stroncek, David F.

PY - 2007

Y1 - 2007

N2 - Background: Adoptive immune and vaccine therapies have been used to prevent cytomegalovirus (CMV) disease in recipients of hematopoietic progenitor cell transplants, but the nature of T cell responses to CMV have not been completely characterized. Methods: Peptide pools and indi vidual peptides derived from the immune-dominant CMV proteins pp65 and IE-1 and antigen-specific, cytokine flow cytometry were used to characterize the prevalence and frequency of CD4+ and CD8+ memory T cells in 20 healthy CMV-seropositive subjects. Results: CD8+ T cell responses to pp65 were detected in 35% o f subjects and to IE-1 in 40% of subjects. CD4+ T cell responses to pp65 were detected in 50% of subjects, but none were detected to IE-1. Several new IE-1 HLA class I epitopes were identified, including 4 restricted to HLA-C antigens. One region of IE-1 spanning amino acids 300 to 327 was rich in class I epitopes. The HLA class I restrictions of IE-1 peptides were more promiscuous than those of pp65 peptides. Conclusion: Since na turally occurring CD4+ and CD8+ T cell responses to pp65 were detectable in many subjects, but only CD8+ T cell responses to IE-1 were detected, pp65 may be better than IE-1 for use in vaccine and adoptive immune therapies.

AB - Background: Adoptive immune and vaccine therapies have been used to prevent cytomegalovirus (CMV) disease in recipients of hematopoietic progenitor cell transplants, but the nature of T cell responses to CMV have not been completely characterized. Methods: Peptide pools and indi vidual peptides derived from the immune-dominant CMV proteins pp65 and IE-1 and antigen-specific, cytokine flow cytometry were used to characterize the prevalence and frequency of CD4+ and CD8+ memory T cells in 20 healthy CMV-seropositive subjects. Results: CD8+ T cell responses to pp65 were detected in 35% o f subjects and to IE-1 in 40% of subjects. CD4+ T cell responses to pp65 were detected in 50% of subjects, but none were detected to IE-1. Several new IE-1 HLA class I epitopes were identified, including 4 restricted to HLA-C antigens. One region of IE-1 spanning amino acids 300 to 327 was rich in class I epitopes. The HLA class I restrictions of IE-1 peptides were more promiscuous than those of pp65 peptides. Conclusion: Since na turally occurring CD4+ and CD8+ T cell responses to pp65 were detectable in many subjects, but only CD8+ T cell responses to IE-1 were detected, pp65 may be better than IE-1 for use in vaccine and adoptive immune therapies.

UR - http://www.scopus.com/inward/record.url?scp=34247159208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247159208&partnerID=8YFLogxK

U2 - 10.1186/1479-5876-5-17

DO - 10.1186/1479-5876-5-17

M3 - Article

C2 - 17391521

AN - SCOPUS:34247159208

VL - 5

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

M1 - 17

ER -